Storage Condition
Refer MSDS for complete information
Synonyms
Bedaquiline-d6 (Mixture of Diastereomers),
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Bedaquiline-d6 (Mixture of Diastereomers) is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Bedaquiline-d6 (Mixture of Diastereomers) usage and description
Bedaquiline-d6 is a deuterated form of Bedaquiline, which is an FDA-approved drug used in the treatment of multi-drug-resistant tuberculosis (MDR-TB). Bedaquiline-d6 is a mixture of diastereomers that have been labeled with deuterium atoms, which are heavy isotopes of hydrogen. The deuterium atoms provide a unique molecular fingerprint that allows for the study of the drug's metabolism and pharmacokinetics.
Bedaquiline-d6 is a type of antibiotic that works by inhibiting the ATP synthase enzyme in the bacteria that cause tuberculosis. This enzyme is responsible for producing the energy that the bacteria need to survive, and by blocking it, bedaquiline-d6 can effectively kill the bacteria. The use of bedaquiline-d6 is a promising new approach to the treatment of MDR-TB, which is a growing problem worldwide.
Chemically, bedaquiline-d6 has a molecular formula of C32H31D6N3O2 and a molar mass of 517.70 g/mol. It is a white to off-white powder that is soluble in dimethyl sulfoxide, ethanol, and methanol. Bedaquiline-d6 is stable under normal storage conditions and has a shelf life of up to two years.
In conclusion, bedaquiline-d6 is a deuterated form of bedaquiline that is used in the treatment of MDR-TB. It works by inhibiting the ATP synthase enzyme in the bacteria that cause tuberculosis, and is a promising new approach to addressing this growing problem. Its chemical properties make it useful for studying the drug's metabolism and pharmacokinetics, which could lead to further improvements in the treatment of tuberculosis.
